Summary & Overview
HCPCS Level II J7299: Intrauterine Copper Contraceptive (miudella)
HCPCS Level II code J7299 designates the intrauterine copper contraceptive product marketed as miudella. As a nonhormonal, long-acting reversible contraceptive (LARC), this device is used for routine contraception and can affect provider billing, inventory management, and patient access to LARC options nationwide. The code matters because it standardizes reporting and reimbursement for a device that may be covered differently across public and commercial payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of clinical context for the device, typical sites of service, and the national relevance for contraception coverage. The publication outlines common billing considerations, reimbursement benchmarks where available, and payer coverage patterns when implemented. It also summarizes coding relationships and practical implications for supply management and claims submission.
This summary provides clinicians, billing professionals, and policy stakeholders with an overview of what HCPCS Level II code J7299 represents, why it is relevant to contraceptive care delivery, and what elements to examine when evaluating coverage and reimbursement for intrauterine copper contraceptives at the national level.
Billing Code Overview
HCPCS Level II code J7299 represents an intrauterine copper contraceptive (miudella). The service involves placement of a nonhormonal, copper-bearing intrauterine device for long-acting reversible contraception. Typical service type: contraceptive device placement / provision.
Typical site of service: outpatient ambulatory clinic or office-based gynecology practice, including family planning clinics. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 29-year-old parous female requests long-acting reversible contraception and elects placement of an intrauterine copper device (J7299, Miudella). She presents to an outpatient gynecology clinic for counseling, informed consent, and a same-day procedure. Preprocedural workflow includes a focused history (contraceptive goals, allergies, prior pelvic infection, recent STI screening), pregnancy testing (urine hCG), and pelvic exam to confirm uterine size and position. If criteria are met, the clinician performs aseptic preparation, bimanual exam, and, if indicated, cervical anesthesia and uterine sounding. The device is loaded and inserted transcervically into the uterine fundus; strings are trimmed. Postprocedure, the patient is observed briefly for vasovagal symptoms, given written and verbal aftercare instructions about expected bleeding and cramping, and scheduled for a follow-up visit in 4–12 weeks to check string placement. Typical site of service is an outpatient office-based gynecology clinic or ambulatory surgical center. Typical patient scenario: healthy reproductive-age person seeking nonhormonal LARC, without contraindications such as active pelvic infection or uterine anomaly.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |